SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : LIPO-Liposome
LIPO 0.330-5.7%Nov 28 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: michael who wrote (492)9/24/1997 11:11:00 AM
From: chuckj   of 900
 
Lipo, from the price revenue ratio standpoint, is currently the best buy in the Biotech sector. The Liposome drug delivery system is the drug delivery system of the future and everyone knows it.

Enough time has elapsed for all the bad news to come out, there was no SEC investigation and there will not be, and there is minimum down side risk and upside potential outweighs any downside risk. Dispite the fact that everyone hates Dart, and does not like to see him make money, as a premier biotech, this stock will be back in the twenties in 3 months.
cj
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext